Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio tech updates on collaboration and license agreement

Jan 24 (Reuters) - Essex Bio-Technology Ltd  1061.HK : 
 * Tech-inside information - collaboration and license agreement and proposed 
   subscription of series c preferred stock and warrants  1061.HK  
 * Says Essex Bio investment and abpro entered into the collaboration and 
   license agreement 
 * Parties agreed to commercialise and jointly develop selected antibodies into 
   licensed products 
 * The collaboration and license agreement is for an initial term of 10 years 
 * Essex Bio investment and abpro entered into the share subscription agreement 
 * Abpro conditionally agreed to issue, 616,197 series c preferred stock for a 
   total consideration of approximately US$3.5 million 
 
* Source text for Eikon  ID:nHKS7J24h6  
 
* ((For more news, please click here  1061.HK )) ((Bengaluru Newsroom; +91 80 
6749 1130))

Recent news on Essex Bio-Technology

See all news